ArticleP & T : a peer-reviewed journal for formulary management2018

Oritavancin (Orbactiv): A New-Generation Lipoglycopeptide for the Treatment Of Acute Bacterial Skin and Skin Structure Infections.

Samantha Rosenthal et al.PubMed ↗Full text ↗

No numbers read from the abstract.